Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells

被引:24
作者
Xu, Zekuan [2 ]
Zhang, Yi [2 ,6 ]
Jiang, Jiakai [2 ]
Yang, Yang [3 ]
Shi, Ruihua [3 ]
Hao, Bo [3 ]
Zhang, Zhihong [4 ]
Huang, Zuhu [5 ]
Kim, Jin W. [1 ]
Zhang, Guoxin [3 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul 137040, South Korea
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing 210029, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing 210029, Peoples R China
[5] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing 210029, Peoples R China
[6] Nanjing Univ Chinese Med, Affiliated Hosp 1, Dept Emergency Surg, Nanjing 210029, Peoples R China
关键词
BREAST-CANCER; PROTEIN EXPRESSION; PROGNOSTIC VALUE; ONCOGENE HCCR-2; AKT; PATHWAY; KINASE; OSTEOPONTIN; SURVIVAL; ADENOCARCINOMA;
D O I
10.1186/1471-2407-10-161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human cervical cancer oncoprotein 1 (HCCR-1), reported as a negative regulator of p53, is overexpressed in a variety of human cancers. However, it is yet unknown whether HCCR-1 plays any role in pancreatic cancer development. The aim of this study was to investigate the effect of epidermal growth factor on the expression of HCCR in pancreatic cancer cells, and to explore if PI3K/Akt/mTOR signaling pathway mediated this expression. Methods: A polyclonal antibody against HCCR protein was raised by immunizing Balb/c mice with the purified recombinant protein pMBPc-HCCR. Tissue samples were constructed on a tissue chip, and the expression of HCCR was investigated by immunohistochemistry assay and Western blotting. Pancreatic cell line, PANC-1 cells were stably transfected with plasmids containing sense-HCCR-1 fragment and HCCR siRNA fragment. MTT and transwell assay were used to investigate the proliferation and invasion of stable tansfectants. The specific inhibitor of PI3K and mTOR was used to see if PI3K/mTOR signal transduction was involved in the induction of HCCR gene expression. A Luciferase assay was used to see if Akt can enhance the HCCR promoter activity. Results: HCCR was up-regulated in pancreatic tumor tissues (mean Allred score 4.51 +/- 1.549 vs. 2.87 +/- 2.193, P < 0.01), especially with high expression in poorly differentiated pancreatic cancer. The growth of cells decreased in HCCR-1 siRNA transfected cells compared with vector transfectants. The number of invasion cells was significantly lower in HCCR-1 siRNA transfected cells (24.4 +/- 9.9) than that in vector transfectants (49.1 +/- 15.4). Treatment of PANC-1 cells with epidermal growth factor increased HCCR protein level in a dose- and time-dependent manner. However, application of LY294002 and rapamycin caused a dramatic reduction of epidermal growth factor-induced HCCR expression. Over-expression of exogenous constitutively active Akt increased the HCCR promoter activity; in contrast, dominant negative Akt decreased the promoter activity. Conclusions: EGF-induced HCCR-1 over-expression is mediated by PI3K/AKT/mTOR signaling which plays a pivotal role in pancreatic tumor progression, suggesting that HCCR-1 could be a potential target for cancer therapeutics.
引用
收藏
页数:11
相关论文
共 37 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[3]   Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells [J].
Asano, T ;
Yao, YX ;
Shin, S ;
McCubrey, S ;
Abbruzzese, JL ;
Reddy, SAG .
CANCER RESEARCH, 2005, 65 (20) :9164-9168
[4]   The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells [J].
Asano, T ;
Yao, YX ;
Zhu, JJ ;
Li, DH ;
Abbruzzese, JL ;
Reddy, SAG .
ONCOGENE, 2004, 23 (53) :8571-8580
[5]   Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].
Baselga, J ;
Arteaga, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459
[6]   A RETROVIRAL ONCOGENE, AKT, ENCODING A SERINE-THREONINE KINASE CONTAINING AN SH2-LIKE REGION [J].
BELLACOSA, A ;
TESTA, JR ;
STAAL, SP ;
TSICHLIS, PN .
SCIENCE, 1991, 254 (5029) :274-277
[7]   TREATMENT AND SURVIVAL IN 13560 PATIENTS WITH PANCREATIC-CANCER, AND INCIDENCE OF THE DISEASE, IN THE WEST MIDLANDS - AN EPIDEMIOLOGIC-STUDY [J].
BRAMHALL, SR ;
ALLUM, WH ;
JONES, AG ;
ALLWOOD, A ;
CUMMINS, C ;
NEOPTOLEMOS, JP .
BRITISH JOURNAL OF SURGERY, 1995, 82 (01) :111-115
[8]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[9]   IGF-I promotes Schwann cell motility and survival via activation of Akt [J].
Cheng, HL ;
Steinway, M ;
Delaney, CL ;
Franke, TF ;
Feldman, EL .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 170 (1-2) :211-215
[10]   The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression [J].
Cho, Goang-Won ;
Shin, Seung Min ;
Namkoong, Hong ;
Kim, Hyun Kee ;
Ha, Seon-Ah ;
Hur, Soo Young ;
Kim, Tae Eung ;
Chai, Young-Gyu ;
Kim, Jin Woo .
GENE, 2006, 384 :18-26